scholarly journals Resilience and Quality of Life: Exploring the Mediator Role of Social Support in Patients with Breast Cancer

2017 ◽  
Vol 23 ◽  
pp. 5969-5979 ◽  
Author(s):  
Hailing Zhang ◽  
Qinghua Zhao ◽  
Peiye Cao ◽  
Guosheng Ren
2016 ◽  
Vol 26 (6) ◽  
pp. 815-821 ◽  
Author(s):  
M. Graça Pereira ◽  
Mafalda Ponte ◽  
Gabriela Ferreira ◽  
José C. Machado

2021 ◽  
Vol 19 (1) ◽  
Author(s):  
Yue Ban ◽  
Mengyao Li ◽  
Mingli Yu ◽  
Hui Wu

Abstract Background Women with breast cancer are prone to have mental stress and be stimulated by the fear of progression (FOP), then giving rise to a lower quality of life (QOL). The study aimed to examine the relationships between FOP, social support and QOL, and further explore whether social support mediates the association between FOP and QOL among Chinese patients with breast cancer. Methods The cross-sectional study was conducted from October 2019 to May 2020 at Anshan Cancer Hospital in Liaoning, China. 244 female breast cancer patients completed questionnaires including the Functional Assessment of Cancer Therapy for Breast (FACT-B), Multi-Dimensional Scale of Perceived Social Support (MSPSS), and Fear of Progression (FOP). Hierarchical multiple regression analysis was performed to assess the associations between FOP, social support and QOL. Asymptotic and resampling strategies were used to explore the mediating role of social support. Results The mean QOL score was 90.6 ± 17.0 among the patients with breast cancer. FOP was negatively correlated with QOL, while social support was positively related to QOL. Social support partly mediated the association between FOP and QOL, and the proportion of the mediating effect accounted for by social support was 25%. Conclusions Chinese breast cancer patients expressed low QOL. Social support could mediate the association between FOP and QOL. Medical staffs and cancer caregivers should alleviate patients’ FOP to improve their QOL by facilitating social support.


2020 ◽  
pp. 385-400
Author(s):  
Jeffrey D. Blaustein

About 1 of every 8 women will develop breast cancer during her lifetime, and approximately 250,000 new cancer cases are expected annually as of 2017. Of those breast cancers, approximately 60% to 75% will express estrogen receptors, suggesting that estrogens are likely to promote growth of those tumors. Because the use of inhibitors of the synthesis of estrogens is the adjuvant treatment of choice for many women, it is essential that we understand the potential adverse effects on quality of life of those treatments. This review addresses the role of estrogens locally synthesized in the brain in laboratory animals and women, the effects of estrogens on cognitive function, the effects of synthesis blockers on cognitive function, and the limitations in performing experiments that will give us strong confidence in the results and conclusions.


2019 ◽  
Vol 28 (5) ◽  
Author(s):  
Suhair Hussni Al‐Ghabeesh ◽  
Mahmoud Al‐Kalaldah ◽  
Ahmad Rayan ◽  
Anwar Al‐Rifai ◽  
Fadwa Al‐Halaiqa

Sign in / Sign up

Export Citation Format

Share Document